BCL9 and hepatocellular carcinoma: We observed similar results in the 40 pairs of primary and recurrent HCC samples, which showed nuclear accumulation of β-catenin in samples with BCL9 mutation or amplification, accompanied by decreased CD8+ cell infiltration (Fig. 8h).